Skip Navigation LinksHome > June 2014 - Volume 34 - Issue 6 > CHOROIDAL THICKNESS IN DIABETIC RETINOPATHY: The Influence o...
Retina:
doi: 10.1097/IAE.0000000000000053
Original Study

CHOROIDAL THICKNESS IN DIABETIC RETINOPATHY: The Influence of Antiangiogenic Therapy

Laíns, Inês MD, MSc*; Figueira, João MD*,†,‡,§; Santos, Ana Rita MSc†,‡; Baltar, Alda BSc*; Costa, Miguel MSc; Nunes, Sandrina MSc; Farinha, Cláudia MD*; Pinto, Rita MD; Henriques, José MD; Silva, Rufino MD, PhD*,†,‡,§

Collapse Box

Abstract

Purpose:

To analyze the effect of anti–vascular endothelial growth factor agents (anti-VEGF) in submacular choroidal thickness (CT) of diabetic retinopathy (DR) patients.

Methods:

Cross-sectional study, which included 25 DR patients (50 eyes) divided in 2 groups, according to DR stage and previous treatments: nonproliferative DR and diffuse diabetic macular edema in both eyes, submitted to macular laser in both eyes and anti-VEGF injection only in 1 eye (nonproliferative diabetic retinopathy + diabetic macular edema group, n = 11); and proliferative DR in both eyes, treated with panretinal photocoagulation in both eyes and anti-VEGF injection only in 1 eye (proliferative diabetic retinopathy group, n = 14). In the study visit, all patients underwent optical coherence tomography with enhanced depth imaging protocol. Choroidal segmentation was performed manually. The medium CT in central macular area (CCT) and the CT in centrofoveal B-scan were obtained automatically.

Results:

The 25 eyes treated with anti-VEGF showed a reduction on CCT (P = 0.002) and subfoveal CT (P = 0.004), compared with the fellow eyes treated with laser only. Independent evaluation of PDR group revealed similar results (CCT, P = 0.02; subfoveal CT, P = 0.03). In nonproliferative diabetic retinopathy + diabetic macular edema group, CCT was also significantly thinner in eyes treated with anti-VEGF (P = 0.04). A correlation between the number of injections and a thinner CT was found in this group (P = 0.03) and in the evaluation of all eyes together (P = 0.03).

Conclusion:

Diabetic eyes treated with anti-VEGF agents have reduced CT.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.